Higher Accuracy of Self-Monitoring of Blood Glucose in Insulin-Treated Patients in Germany: Clinical and Economical Aspects

Abstract

Background:

Accuracy standards of blood glucose (BG) meters are currently under review. Revised standards are expected to tighten accuracy requirements. Regarding clinical and financial impact of BG meter accuracy, very little data are available. The aim of this study was to analyze potential cost savings related to higher accuracy of glucose meters in Germany.

Methods:

As a model for calculation, a reduction of meter error from 20% to 5% was applied. The health economic analysis was based on four main pillars: (1) number of insulin-treated patients; (2) costs for glucose monitoring in Germany; (3) data of a modeling analysis on the impact on hypoglycemic episodes, glycosylated hemoglobin (HbA1c), and, subsequently, myocardial infarctions; and (4) costs of diabetes-related complications in Germany. A reduction of meter error from 20% to 5% was identified to be associated with a 10% reduction in severe hypoglycemic episodes and a 0.39% reduction in HbA1c, which translates into a 0.5% reduction of myocardial infarctions.

Results:

According to the health economic analysis, the reduction in severe hypoglycemic episodes and myocardial infarctions led to cost savings of €24.14 per patient per year. Considering 390,000 type 1 diabetes patients or 2.3 million insulin-treated patients in Germany, these savings could be equal to a reduction in health care expenditures of more than €9.4 million and €55.5 million, respectively.

Conclusions:

Potential cost savings and clinical effects due to higher accuracy of BG meters should provide an impetus to implementation of tighter accuracy standards and development of glucose meters that provide highest possible accuracy.

Keywords

accuracy cost analysis diabetes hypoglycemia self-monitoring of blood glucose

References

American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012; 35 Suppl 1: S11–63.

Kovatchev

Otto

Cox

Gonder-Frederick

Clarke

. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006; 29 (11): 2433–8.

Schnell

Alawi

Battelino

Ceriello

Diem

Felton

Grzeszczak

Harno

Kempler

Satman

Vergès

. Consensus statement on self-monitoring of blood glucose in diabetes: A European perspective. Diabetes Stoffwechsel Herz. 2009; 18 (4): 285–9.

Peel

Parry

Douglas

Lawton

. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: A qualitative study of patients' perspectives. Br J Gen Pract. 2004; 54 (500): 183–8.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352 (9131): 837–53.

ACCORD Study Group, Cushman

Evans

Byington

Goff

Jr Grimm

Jr Cutler

Simons-Morton

Basile

Corson

Probstfield

Katz

Peterson

Friedewald

Buse

Bigger

Gerstein

Ismail-Beigi

. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362 (17): 1575–85.

ADVANCE Collaborative Group, Patel

MacMahon

Chalmers

Neal

Billot

Woodward

Marre

Cooper

Glasziou

Grobbee

Hamet

Harrap

Heller

Liu

Mancia

Mogensen

Pan

Poulter

Rodgers

Williams

Bompoint

de Galan

Joshi

Travert

. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358 (24): 2560–72.

Duckworth

Abraira

Moritz

Reda

Emanuele

Reaven

Zieve

Marks

Davis

Hayward

Warren

Goldman

McCarren

Vitek

Henderson

Huang

; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360 (2): 129–39.

Polonsky

Fisher

Schikman

Hinnen

Parkin

Jelsovsky

Petersen

Schweitzer

Wagner

. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the Structured Testing Program study. Diabetes Care. 2011; 34 (2): 262–7.

10.

Franciosi

Lucisano

Pellegrini

Cantarello

Consoli

Cucco

Ghidelli

Sartore

Sciangula

Nicolucci

; ROSES Study Group. ROSES: Role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med. 2011; 28 (7): 789–96.

11.

Durán

Martín

Runkle

Pérez

Abad

Fernández

Del Valle

Sanz

Calle-Pascual

. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010; 2 (3): 203–11.

12.

Tengblad

Grodzinsky

Lindstrom

Molstad

Borgquist

Ostgren

. Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. Scand J Prim Health Care. 2007; 25 (3): 140–6.

13.

Farmer

Wade

Goyder

Yudkin

French

Craven

Holman

Kinmonth

Neil

. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open parallel group randomised trial. BMJ. 2007; 335 (7611): 132.

14.

Simon

Gray

Clarke

Wade

Neil

Farmer

; Diabetes Glycaemic Education and Monitoring Trial Group. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: Economic evaluation of data from the DiGEM trial. BMJ. 2008; 336 (7654): 1177–80.

15.

International Organization for Standardization. In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197: 2003. http://www.iso.org/iso/home/store/catalogue_to/catalogue_detail.htm?csnumber=26309.

16.

International Organization for Standardization. In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197. http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.htm?csnumber=54976.

17.

Breton

Kovatchev

. Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: An in silico study. J Diabetes Sci Technol. 2010; 4 (3): 562–70.

18.

Heidemann

Scheidt-Nave

. Diabetes mellitus in Germany. GBE kompakt. Berlin: Robert Koch Institute; 2011.

19.

DiabetesIDE. Deutscher Gesundheitsbericht Diabetes. Mainz: Kirchheim + Co. GmbH; 2012.

20.

Koster

Huppertz

Hauner

Schubert

. Direct costs of diabetes mellitus in Germany — CoDiM 2000–2007. Exp Clin Endocrinol Diabetes. 2011; 119 (6): 377–85.

21.

Diabetes Research in Children Network (DirecNet) Study Group. Relative accuracy of the BD Logic and FreeStyle blood glucose meters. Diabetes Technol Ther. 2007; 9 (2): 165–8.

22.

Fendler

Hogendorf

Szadkowska

Mlynarski

. Non-coding glucometers among pediatric patients with diabetes: Looking for the target population and an accuracy evaluation of no-coding personal glucometer. Pediatr Endocrinol Diabetes Metab. 2011; 17 (2): 57–63.

23.

Frank

Wallace

Pardo

Parkes

. Performance of the CONTOUR® TS Blood Glucose Monitoring System. J Diabetes Sci Technol. 2011; 5 (1): 198–205.

24.

Freckmann

Baumstark

Jendrike

Zschornack

Kocher

Tshiananga

Heister

Haug

. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther. 2010; 12 (3): 221–31.

25.

Hsu

Hsiao

Lee

Chang

Lee

Tsai

Zen

. Assessing the quality of Bionime self-monitoring blood glucose system Rightest GM110: A critical evaluation of interference and ambient circumstances. Clin Chim Acta. 2009; 402 (1–2): 119–23.

26.

Kipnes

Joseph

Morris

Manko

Bell

. Clinical performance of the TRUE2go blood glucose system—a novel integrated system for meter and strips. Diabetes Technol Ther. 2009; 11 (10): 649–55.

27.

Kuo

Hsu

Wang

. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther. 2011; 13 (5): 596–600.

28.

Lippi

Salvagno

Guidi

Negri

Rizzotti

. Evaluation of four portable self-monitoring blood glucose meters. Ann Clin Biochem. 2006; 43 (Pt 5): 408–13.

29.

Solnica

Kusnierz-Cabala

Slowinska-Solnica

Witek

Cempa

Malecki

. Evaluation of the analytical performance of the coulometry-based optium omega blood glucose meter. J Diabetes Sci Technol. 2011; 5 (6): 1612–7.

30.

Boren

Clarke

. Analytical and clinical performance of blood glucose monitors. J Diabetes Sci Technol. 2010; 4 (1): 84–97.

31.

Dalla

Man C

Raimondo

Rizza

Cobelli

. GIM, simulation software of meal glucose-insulin model. J Diabetes Sci Technol. 2007; 1 (3): 323–30.

32.

Dalla

Man C

Rizza

Cobelli

. Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng. 2007; 54 (10): 1740–9.

33.

Kovatchev

Breton

Man

Cobelli

. In silico preclinical trials: A proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009; 3 (1): 44–55.

34.

Magni

Raimondo

Bossi

Man

De Nicolao

Kovatchev

Cobelli

. Model predictive control of type 1 diabetes: An in silico trial. J Diabetes Sci Technol. 2007; 1 (6): 804–12.

35.

Cryer

. Hypoglycaemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002; 45 (7): 937–48.

36.

Cryer

. The pathophysiology of hypoglycaemia in diabetes. Diabetes Nutr Metab. 2002; 15 (5): 330–3.

37.

Nathan

Kuenen

Borg

Zheng

Schoenfeld

Heine

; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31 (8): 1473–8.

38.

UKPDS Risk Engine: http://www.dtu.ox.ac.uk/riskengine/.

39.

The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997; 46 (2): 271–86.

40.

Bragd

Adamson

Lins

Wredling

Oskarsson

. A repeated cross-sectional survey of severe hypoglycaemia in 178 type 1 diabetes mellitus patients performed in 1984 and 1998. Diabet Med. 2003; 20 (3): 216–9.

41.

Bott

Berger

Muhlhauser

. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia. 1997; 40 (8): 926–32.

42.

Müller

Femerling

Reinauer

Risse

Voss

Jörgens

Berger

Mühlhauser

. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care. 1999; 22 Suppl 2: B29–34.

43.

Schiel

Muller

. Structured treatment and teaching programs and an improvement in private health care lead to a better quality of diabetes care. JEVIN, a population-based trial 1989/90 up to 1999/2000. Med Klin (Munich). 2003; 98 (6): 303–12.

44.

Leese

Wang

Broomhall

Kelly

Marsden

Morrison

Frier

Morris

; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use. Diabetes Care. 2003; 26 (4): 1176–80.

45.

Farmer

Brockbank

Keech

England

Deakin

. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med. 2012; 29 (11): 1447–50.

46.

Bayerische Staatskanzlei. Bayerisches Rettungsdienstgesetz (BayRDG). http://www.gesetze-bayern.de/jportal/portal/page/bsbayprod.psml?showdoccase=1&doc.id=jlr-RettDGBY2008rahmen&doc.part=X&doc.origin=bs.

47.

G-DRG Fallpauschalen-Katalog 2012. http://www.g-drg.de/cms/G-DRG-System2012/Fallpauschalen-Katalog/Fallpauschalen-Katalog 2012.

48.

vdek. Landesweite Basisfallwerte. http://www.vdek.com/vertragspartner/Krankenhaeuser/DRG/landesbasisfallwerte/1_lbfw_2012_mit_Tarifrate.pdf.

49.

Hamm

. Guidelines: Acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation. Z Kardiol. 2004; 93 (4): 324–41.

50.

Bruckenberger

. Multidisciplinary health report on cardiology and cardiac surgery. ISBN 978-3-00-032101-6; 2009.

51.

Liebl

Neiss

Spannheimer

Reitberger

Wieseler

Stammer

Goertz

. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany—results from the CODE-2 study. Exp Clin Endocrinol Diabetes. 2002; 110 (1): 10–6.

52.

Roehnisch

Behrens

Maier

. Influence of guideline-based treatment in myocardial infarction patiens with and without diabetes mellitus. Dtsch Aerztebl. 2007; 104 (40), A2724–9.

53.

Koster

von Ferber

Ihle

Schubert

Hauner

. The cost burden of diabetes mellitus: The evidence from Germany—the CoDiM study. Diabetologia. 2006; 49 (7): 1498–504.

54.

Kanavos

van den Aardweg

Schurer

. Diabetes expenditure, burden of disease and management in 5 EU countries. London: London School of Economics; 2012. http://www2.lse.ac.uk/LSEHealthAndSocialCare/research/LSEHealth/MTRG/LSEDiabetesReport26Jan2012.pdf.

55.

Schnell

Amann-Zalan

Jelsovsky

Moritz

Bermejo

Parkin

Schweitzer

Fisher

Polonsky

. Changes in A1C levels are significantly associated with changes in levels of the cardiovascular risk biomarker hs-CRP: Results from SteP Study. Diabetes Care. 2013. Epub ahead of print.

56.

Klonoff

Blonde

Cembrowski

Chacra

Charpentier

Colagiuri

Dailey

Gabbay

Heinemann

Kerr

Nicolucci

Polonsky

Schnell

Vigersky

Yale

; Coalition for Clinical Research-Self-Monitoring of Blood Glucose Scientific Board. Consensus report: The current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2011; 5 (6): 1529–48.

57.

Schnell

Alawi

Battelino

Ceriello

Diem

Felton

Grzeszczak

Harno

Kempler

Satman

Vergès

. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: A European perspective and expert recommendation. Diabetes Technol Ther. 2011; 13 (9): 959–65.

58.

International Diabetes Federation. Global guideline for type 2 diabetes (2005). http://www.idf.org/global-guideline-type-2-diabetes-2005.

59.

Welschen

Bloemendal

Nijpels

Dekker

Heine

Stalman

Bouter

. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: A systematic review. Diabetes Care. 2005; 28 (6): 1510–7.

60.

Malanda

Welschen

Riphagen II Dekker

Nijpels

Bot

. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012; 1: CD005060.

61.

Schnell

Alawi

Battelino

Ceriello

Diem

Felton

Grzeszczak

Harno

Hummel

Kempler

Satman

Vergès

. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin: Letter to the editor. Cochrane Database Syst Rev. 2012; 1: CD005060.